135 related articles for article (PubMed ID: 34602564)
1. Resolvin E1 Attenuates Chronic Pain-Induced Depression-Like Behavior in Mice: Possible Involvement of Chemerin Receptor ChemR23.
Suzuki H; Otsuka T; Hitora-Imamura N; Ishimura K; Fukuda H; Fujiwara K; Shuto S; Deyama S; Minami M
Biol Pharm Bull; 2021; 44(10):1548-1550. PubMed ID: 34602564
[TBL] [Abstract][Full Text] [Related]
2. Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23.
Deyama S; Shimoda K; Suzuki H; Ishikawa Y; Ishimura K; Fukuda H; Hitora-Imamura N; Ide S; Satoh M; Kaneda K; Shuto S; Minami M
Psychopharmacology (Berl); 2018 Jan; 235(1):329-336. PubMed ID: 29090333
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D2 attenuates chronic pain-induced depression-like behavior in mice.
Suzuki H; Hitora-Imamura N; Deyama S; Minami M
Neuropsychopharmacol Rep; 2021 Sep; 41(3):426-429. PubMed ID: 34291613
[TBL] [Abstract][Full Text] [Related]
4. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.
Arita M; Ohira T; Sun YP; Elangovan S; Chiang N; Serhan CN
J Immunol; 2007 Mar; 178(6):3912-7. PubMed ID: 17339491
[TBL] [Abstract][Full Text] [Related]
5. The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice.
Aoki S; Deyama S; Sugie R; Ishimura K; Fukuda H; Shuto S; Minami M; Kaneda K
Behav Brain Res; 2022 Feb; 418():113676. PubMed ID: 34801580
[TBL] [Abstract][Full Text] [Related]
6. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages.
Herová M; Schmid M; Gemperle C; Hersberger M
J Immunol; 2015 Mar; 194(5):2330-7. PubMed ID: 25637017
[TBL] [Abstract][Full Text] [Related]
7. Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice.
Deyama S; Shimoda K; Ikeda H; Fukuda H; Shuto S; Minami M
J Pharmacol Sci; 2018 Sep; 138(1):86-88. PubMed ID: 30293959
[TBL] [Abstract][Full Text] [Related]
8. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
[TBL] [Abstract][Full Text] [Related]
9. Resolvin E1/ChemR23 Protects Against Hypertension and Vascular Remodeling in Angiotensin II-Induced Hypertensive Mice.
Zhang J; Yin Z; Xu Y; Wei C; Peng S; Zhao M; Liu J; Xu S; Pan W; Zheng Z; Liu S; Ye J; Qin JJ; Wan J; Wang M
Hypertension; 2023 Dec; 80(12):2650-2664. PubMed ID: 37800344
[TBL] [Abstract][Full Text] [Related]
10. [Resolvin E1 as a potential lead for the treatment of depression].
Deyama S; Minami M; Kaneda K
Nihon Yakurigaku Zasshi; 2024; 159(4):210-213. PubMed ID: 38945902
[TBL] [Abstract][Full Text] [Related]
11. Resolvin E1 Ameliorates Pulpitis by Suppressing Dental Pulp Fibroblast Activation in a Chemerin Receptor 23-dependent Manner.
Xu H; Chen J; Ge J; Xia K; Tao S; Su Y; Zhang Q
J Endod; 2019 Sep; 45(9):1126-1134.e1. PubMed ID: 31353056
[TBL] [Abstract][Full Text] [Related]
12. Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitis.
Ishida T; Yoshida M; Arita M; Nishitani Y; Nishiumi S; Masuda A; Mizuno S; Takagawa T; Morita Y; Kutsumi H; Inokuchi H; Serhan CN; Blumberg RS; Azuma T
Inflamm Bowel Dis; 2010 Jan; 16(1):87-95. PubMed ID: 19572372
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway.
Deyama S; Ishikawa Y; Yoshikawa K; Shimoda K; Ide S; Satoh M; Minami M
Int J Neuropsychopharmacol; 2017 Jul; 20(7):575-584. PubMed ID: 28419244
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1.
Arita M; Bianchini F; Aliberti J; Sher A; Chiang N; Hong S; Yang R; Petasis NA; Serhan CN
J Exp Med; 2005 Mar; 201(5):713-22. PubMed ID: 15753205
[TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 Inhibits Substance P-Induced Potentiation of TRPV1 in Primary Sensory Neurons.
Jo YY; Lee JY; Park CK
Mediators Inflamm; 2016; 2016():5259321. PubMed ID: 27738388
[TBL] [Abstract][Full Text] [Related]
16. Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
Ohira T; Arita M; Omori K; Recchiuti A; Van Dyke TE; Serhan CN
J Biol Chem; 2010 Jan; 285(5):3451-61. PubMed ID: 19906641
[TBL] [Abstract][Full Text] [Related]
17. Chemerin/ChemR23 axis promotes inflammation of glomerular endothelial cells in diabetic nephropathy.
Shang J; Wang L; Zhang Y; Zhang S; Ning L; Zhao J; Cheng G; Liu D; Xiao J; Zhao Z
J Cell Mol Med; 2019 May; 23(5):3417-3428. PubMed ID: 30784180
[TBL] [Abstract][Full Text] [Related]
18. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation.
Gao L; Faibish D; Fredman G; Herrera BS; Chiang N; Serhan CN; Van Dyke TE; Gyurko R
J Immunol; 2013 Jan; 190(2):689-94. PubMed ID: 23241890
[TBL] [Abstract][Full Text] [Related]
19. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.
Campbell EL; Louis NA; Tomassetti SE; Canny GO; Arita M; Serhan CN; Colgan SP
FASEB J; 2007 Oct; 21(12):3162-70. PubMed ID: 17496159
[TBL] [Abstract][Full Text] [Related]
20. Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury.
Xu ZZ; Berta T; Ji RR
J Neuroimmune Pharmacol; 2013 Mar; 8(1):37-41. PubMed ID: 22878925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
